Dadun Dadun cabecera universidad cabecera biblioteca
   (New user)
Help  | Contact  |  Castellano English  
 

Dadun > Depósito Académico > Clínica Universidad de Navarra > Farmacología clínica > DA - CUN - Farmacología clínica - Artículos de revista >

TAK1 mRNA Expression in the Tumor Tissue of Locally Advanced Head and Neck Cancer Patients
Authors: Honorato, B. (Beatriz)
Alcalde, J. (Juan)
Martinez-Monge, R. (Rafael)
Garcia-Foncillas, J. (Jesús)
Zabalegui, N. (Natalia)
Keywords: Real-time PCR
Molecular markers
TAK1
Issue Date: 2008
Publisher: Libertas Academica
Publisher version: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2733096/?tool=pubmed
ISSN: 1177-6250
Citation: Honorato B, Alcalde J, Martinez-Monge R, Zabalegui N, Garcia-Foncillas J. TAK1 mRNA expression in the tumor tissue of locally advanced head and neck cancer patients. Gene Regul Syst Bio 2008 Feb 14;2:63-70.
Abstract
Resistance to radio and chemotherapy is one of the major drawbacks in the progression of head and neck squamous cell cancer (HNSCC) patients, evidencing the importance of finding optimum molecular prognosis markers to develop personalized treatment schedules. TGF-β effector TAK1 activity has been related to a greater aggressiveness in several types of cancer (Kondo et al. 1998; Edlund et al. 2003; Kaur et al. 2005) and, although there has been described no significant implication of TAK1 in HNSCC development, we have further examined the role of its mRNA expression as a marker of prognosis in HNSCC. Fifty-nine advanced HNSCC patients were recruited for the study. The tumor expression of TAK1 mRNA was analyzed with RT-PCR using Taqman technology and its relationship with the clinical outcome of the patients studied. TAK1 mRNA expression was lower in patients that relapsed than in those that did not, but the difference was only significant between the patients that showed response to treatment (p < 0.001). ROC curve analyses pointed a 0.5 expression ratio TAK1/B2M value as an optimum cut-off point for relapse and response. Our data suggest the TAK1 mRNA analysis by Taqman RT-PCR can predict the risk of relapse in HNSCC patients.
Permanent link: http://hdl.handle.net/10171/23495
Appears in Collections:DA - CUN - Oncología radioterápica - Artículos de revista
DA - CUN - Otorrinolaringología - Artículos de revista
DA - CIMA - Oncología - Inmunoterapia - Artículos de Revista
DA - CUN - Oncología médica - Artículos de revista
DA - CUN - Unidad de Genética clínica - Artículos de revista
DA - CUN - Farmacología clínica - Artículos de revista

Files in This Item:
File:  Gene Regul Syst Bio 2008. 63.pdf
Description: 
Size:  454,66 kB
Format:  Adobe PDF
 View / Open 

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.